Fusion Fuel Green PLC - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on December 13, 2022, provides unaudited interim financial statements and business updates for Fusion Fuel Green PLC for the nine months ended September 30, 2022. The Company is a foreign private issuer incorporated in Ireland, focused on developing and commercializing green hydrogen technology (HEVO-Solar) and electrolyzers. The reporting period covers significant operational milestones, including the commissioning of the H2Évora plant and the securing of major grant funding in Portugal and Spain.
Key Financial Metrics
| Metric (€'000) | 9 Months Ended Sep 30, 2022 | 9 Months Ended Sep 30, 2021 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Sales | (1,172) | 0 |
| Operating Loss | (16,086) | (19,608) |
| Net Finance Income | 6,084 | 18,026 |
| Total Comprehensive Loss | (10,558) | (1,582) |
| Cash and Cash Equivalents (End of Period) | 3,610 | 7,875 |
| Net Cash Used in Operating Activities | (23,360) | (15,624) |
| Total Assets | 60,084 | 69,249 |
| Total Liabilities | 16,323 | 19,737 |
| Shareholders' Equity | 43,761 | 49,512 |
Debt and Liquidity: The Company reported no external debt as of September 30, 2022. Current liabilities include approximately €9.74 million in derivative financial instruments (warrants). Cash reserves decreased by approximately €4.2 million during the period.
Material Changes vs. Prior Period
- Loss Reduction: The total comprehensive loss decreased significantly from €1.58 million in the prior year to €10.56 million in the current period, though the operating loss narrowed slightly from €19.61 million to €16.09 million. The prior year loss was heavily impacted by a €14.69 million share-based payment expense, compared to €2.63 million in the current period.
- Project Impairment: A material change in the current period is the recognition of a €1.17 million impairment charge on inventory and a €0.71 million onerous contract provision related to the Exolum project in Spain, totaling approximately €1.88 million in expected losses for that specific contract.
- Derivative Gains: Net finance income was driven by a €5.54 million fair value gain on warrants in the current period, compared to €15.88 million in the prior period.
- Asset Growth: Property, plant, and equipment increased from €18.11 million to €28.27 million, reflecting the completion of the HEVO production line in Benavente, Portugal.
Guidance, Outlook, and Risks
Outlook and Milestones:
- Production Capacity: The Company expects to achieve 100 MW of electrolyzer production capacity in 2023, increasing to approximately 500 MW by 2025.
- Grant Funding: The Company secured €36 million in grant funding for the "Sines Green Hydrogen Valley Alliance" (€22.5 million allocated to the H2 HEVO-SINES project) and €10 million for the HEVO-Industria project. Additionally, four projects in Spain were pre-selected for up to €12.9 million in funding.
- Commercial Agreements: New contracts include a €5 million agreement with Gedisol Energía (Spain), a €2 million agreement with KEME Energy (Portugal), and a joint venture with Electus Energy for a 75 MW project in California.
Risks and Contingencies:
- Going Concern: Management has raised significant doubt about the Company's ability to continue as a going concern absent mitigating actions. The Company has an accumulated deficit of €174.99 million and expects to continue incurring net losses.
- Liquidity Dependence: Operations are highly dependent on securing additional funding through debt, equity, or grants. Management anticipates a sale and leaseback of its production facility (expected €7.5–8.5 million inflow) and a working capital credit facility (approx. €2.5 million) to fund operations for at least one year.
- Project Execution: There is no assurance that announced projects (e.g., Exolum, Bakersfield) will proceed to final investment decision or completion. The Exolum project is currently projected to be loss-making.
Investor Verification Checklist
- Cash Runway: Verify the closing of the anticipated sale and leaseback transaction and the working capital credit facility to confirm the "going concern" assessment.
- Exolum Project Status: Monitor the final loss realization on the Exolum contract and the success of grant applications intended to offset these losses.
- Grant Disbursement: Confirm the actual receipt of the €36 million Sines Alliance grant and the €10 million HEVO-Industria grant, as these are critical for liquidity.
- ATM Utilization: Track the utilization of the $30 million At-the-Market (ATM) issuance facility, noting the significant drop in share price (from $7.35 to $4.02 average) in recent sales.
- Production Ramp-up: Validate the timeline for reaching 100 MW production capacity in 2023 and the commercial deployment of the HEVO-Chain system.